focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJtc Plc Regulatory News (JTC)

Share Price Information for Jtc Plc (JTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 912.00
Bid: 910.00
Ask: 913.00
Change: -6.00 (-0.65%)
Spread: 3.00 (0.33%)
Open: 917.00
High: 921.00
Low: 910.00
Prev. Close: 918.00
JTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Independent Non-Executive Director

25 Mar 2022 07:00

RNS Number : 9750F
JTC PLC
25 March 2022
 

25 March 2022

JTC PLC

(the "Company" and together with its subsidiaries "JTC" or the "Group")

Appointment of Independent Non-Executive Director

JTC is pleased to announce the appointment of Kate Beauchamp as an Independent Non-Executive Director of the Company, joining the Board with effect from 24 March 2022. Kate has also been appointed as an additional member of the Board's Audit and Risk, Nomination and Remuneration Committees.

Kate is a qualified lawyer with more than 20 years' experience in both private and commercial practice and in the provision of corporate and legal advisory services in both the UK and USA.

In 2014 Kate was appointed the Chief Legal Officer of a British-based group of international engineering companies, assuming the Chief Executive Officer role in 2020, with a mandate to deliver a series of divestments following the family owner's intentional strategy of maximising value and the subsequent crystallisation of their operating business and real estate assets.

In addition to her executive role, Kate acts as an independent consultant on good governance and board effectiveness to private and public companies, and has lectured on property, trusts and equity (UK) law.

Mike Liston OBE, Non-Executive Chairman of JTC PLC, said:

"We are delighted that Kate has agreed to join the Board, her experience in a number of JTC's key markets as an executive and as corporate counsel is a welcome addition to the Board. Kate's particular strengths in the areas of corporate governance and law, mergers & acquisitions, contract negotiation and commercial litigation will complement the skills of the existing Board members and we look forward to working with her."

Kate Beauchamp, added:

"Having built my career around managing risk, protecting assets and advocating for good corporate governance, it is a privilege to be joining JTC, an exemplar amongst global professional services firms. I very much look forward to working with my new Board colleagues to support JTC's unique culture, commitment to excellence and sustainable growth ambitions."

No further information is required to be disclosed pursuant to Listing Rule 9.6.13R.

Further information:

Miranda Lansdowne

Group Company Secretary

+44 1534 700 000

Miranda.Lansdowne@jtcgroup.com

 

About JTC

JTC is a publicly listed, global professional services business with deep expertise in fund, corporate and private client services. Every JTC person is an owner of the business and this fundamental part of our culture aligns us with the best interests of all our stakeholders. Our purpose is to maximize potential and our success is built on service excellence, long-term relationships and technology capabilities that drive efficiency and add value.

www.jtcgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRGDXCXDDGDS
Date   Source Headline
22nd Jul 20227:00 amRNSPre-close Interim Update and Notice of Results
15th Jul 20227:00 amRNSNomination Committee Appointment
8th Jul 202211:43 amRNSDirector's Share Dealing
30th Jun 20227:00 amRNSTotal Voting Rights
17th Jun 20224:41 pmRNSSecond Price Monitoring Extn
17th Jun 20224:35 pmRNSPrice Monitoring Extension
14th Jun 20227:00 amRNSIssue of Equity and Total Voting Rights
13th Jun 20224:00 pmRNSDirector's Share Dealing
13th Jun 20229:38 amRNSDirector's Share Dealing
1st Jun 20227:00 amRNSResult of AGM
5th May 202211:09 amRNSPDMR Shareholding
3rd May 20229:02 amRNSDirector's Other Appointments
28th Apr 20227:00 amRNSAnnual Financial Report and Notice of AGM
20th Apr 20227:00 amRNSVest and Grant of Conditional Share Awards
20th Apr 20227:00 amRNSDirector's Share Dealing
19th Apr 20227:00 amRNSFull Year Results
25th Mar 20227:00 amRNSAppointment of Independent Non-Executive Director
28th Feb 202210:00 amRNSPDMR Shareholding
22nd Feb 20228:59 amRNSDirector's Other Appointments
14th Feb 20229:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:00 amRNSPDMR Shareholding
4th Feb 202212:00 pmRNSNotification of Director's Share Dealing
3rd Feb 20227:00 amRNSPre-close Full Year Trading Update
1st Feb 202210:00 amRNSPDMR Shareholding
1st Feb 20229:24 amRNSHolding(s) in Company
28th Jan 202212:51 pmRNSPDMR and PCA Shareholding Notification
31st Dec 20219:33 amRNSDirector's Other Appointments
31st Dec 20217:00 amRNSTotal Voting Rights
22nd Dec 20217:00 amRNSDirector's Other Appointments
21st Dec 20219:26 amRNSHolding(s) in Company
16th Dec 20217:00 amRNSAcquisition of Essential Fund Services, LLC
2nd Dec 20217:00 amRNSCompletion of Acquisition and Issue of Equity
23rd Nov 20213:58 pmRNSHolding(s) in Company
22nd Nov 20217:00 amRNSIssue of Equity
19th Nov 20217:00 amRNSAdmission of Shares
12th Nov 20212:56 pmRNSCompletion of Acquisition and Issue of Equity
26th Oct 20214:28 pmRNSHolding(s) in Company
11th Oct 20213:37 pmRNSHolding(s) in Company
8th Oct 20212:08 pmRNSHolding(s) in Company
7th Oct 20217:00 amRNSRESULTS OF PLACING
6th Oct 20215:02 pmRNSPROPOSED PLACING OF NEW ORDINARY SHARES
6th Oct 20214:59 pmRNSAcquisition of SALI
21st Sep 20217:01 amRNSInterim Results
21st Sep 20217:00 amRNSAcquisition of Ballybunion Capital Limited
17th Sep 20217:00 amRNSIssue of Equity
16th Sep 20217:00 amRNSAcquisition of Segue Partners
3rd Sep 20219:12 amRNSDirector's Other Appointments
23rd Aug 202110:00 amRNSDirector/PDMR Shareholding
19th Aug 20212:00 pmRNSNotification of Share Pledge by PDMR
11th Aug 20219:38 amRNSDirector's Other Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.